Efficacy and safety of traditional Chinese medicine in the treatment of chronic pulmonary diseases: a systematic review and meta-analysis
- PMID: 40520795
- PMCID: PMC12162991
- DOI: 10.3389/fmed.2025.1512729
Efficacy and safety of traditional Chinese medicine in the treatment of chronic pulmonary diseases: a systematic review and meta-analysis
Abstract
Background: To assess the efficacy and safety of various TCMIs treatments for COPD using network meta-analysis, providing evidence and guidance for clinical practice.
Methods: We will search 7 databases for randomized controlled trials of TCMI for the COPD, including PubMed, the Cochrane Library, EMbase, China National Knowledge Infrastructure, China Biological Medicine, Chinese Scientific Journals Database, and Wan-fang databases, from the date of the establishment of each database to October 31, 2021. The network meta-analysis will be implemented through Aggregate Data Drug Information System 1.16.8 and Stata13.0 software. Pulmonary function included forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), and FEV1/FVC will be the primary outcomes, FEV1 as a percentage of the estimated value, maximal voluntary ventilation (MVV), MVV as a percentage of the estimated value, 6 min walking distance, The St.
Results: A total of seven appropriate studies were identified, encompassing 490 patients. The quality of the literature was satisfactory, with no significant publication bias detected. The effectiveness rate for patients receiving a combination of TCM and Western Medicine (WM) compared to those on WM alone was evaluated as an odds ratio (OR), with statistical testing yielding Z = 6.09. For PO2 levels post-treatment, the mean difference (MD) was reported as 5.92.
Conclusion: The results of this study will evaluate the efficacy and safety of TCMI in the treatment of COPD, and provide decision-making references for future clinical and scientific research.
Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251047046, identifier CRD420251047046.
Keywords: chronic obstructive pulmonary disease (COPD); injections; meta-analysis; systematic review; traditional Chinese medicine.
Copyright © 2025 An and Cai.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures





References
-
- Zhang Y, Tingqian L, Wang G, Chen J, Bing M, Wang L. Randomized controlled trial of TanReqing injection in treatment of acute exacerbation of chronic obstructive pulmonary disease (syndrome of retention of phlegm-heat in the lung). Chinese J Evid-Based Med. (2004) 5:300–7. 10.3969/j.issn.1672-2531.2004.05.004 - DOI
-
- He B. Clinical study of tanreqing injection on acute exacerbation of chronic obstructive pulmonary disease. China J Chinese Med. (2014) 2:189–92. doi: CNKI:SUN:HNZK.0.2014-02-014
-
- Li W, Mao B, Wang G, Wang L, Chang J, Zhang Y, et al. [A study of the mechanism of Qingre Huatan therapy in treatment of acute exacerbation of chronic obstructive pulmonary disease by improving airway inflammation and mucus hypersecretion]. Zhong Xi Yi Jie He Xue Bao. (2008) 6:799–805. 10.3736/jcim20080806 - DOI - PubMed
-
- Yonghong X, Faguang J, Tonggang L, Enqing F, Yani S. Curative effect of Tanreqing injection on acute exacerbation of chronic obstructive pulmonary disease. J Emerg Tradit Chin Med. (2005) 4:291–2. 10.3969/j.issn.1004-745X.2005.04.002 - DOI
-
- Jiu H, Yang X. Study on effect of Tanreqing injection for Ptients with chronic obstructive pulmonary disease and acute respiratory failure. J Emerg TCM. (2008) 4:445–7. 10.3969/j.issn.1004-745X.2008.04.012 - DOI
Publication types
LinkOut - more resources
Full Text Sources